Effets of high dose UVA1 phototherapy on cutaneous fibrosis and endothelial cell function in patients with systemic sclerosis

niversity of Dundee (UK)0 个研究点目标入组 20 人开始时间: 2008年2月8日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1. Patients with SSc (both limited and diffuse disease pattern) as diagnosed according to the American College of Rheumatology preliminary classification criteria for this condition
•2. SSc patients with cutaneous manifestations
•3. SSc patients whose diagnosis was made within the previous 3 years
•4. SSc patients who are capable of providing a written informed consent
•5. Patients of either sex and aged 18 or above will be recruited

•1. Patients who have received phototherapy in the previous three months
•2. Patients who have been started on immunosuppressive treatment within the previous 6 months
•3. Patients with localised or generalised morphoea
•4. Patients with other sclerodermas other than that associated with SSc. Examples of other forms of sclerodermas include occupational scleroderma (e.g. vinyl chloride disease), ?scleroporphyria? (a generalised morphoea picture arising due to porphyria cutanea tarda), acrosclerosis atrophicans (a late feature of some patterns of Lyme borreliosis, a tick-borne spirochaetal infection) and nephrogenic fibrosing dermopathy.
•5. Pregnant or breastfeeding women
•6. Subjects who are 18 years or under

发起方

niversity of Dundee (UK)